Staicu ML, Vyles D, Shenoy ES, Stone CA, Banks T, Alvarez KS, et al. Penicillin allergy delabeling: a multidisciplinary opportunity. J Allergy Clin Immunol Pract. 2020;8(9):2858-68.e16.

Article  PubMed  PubMed Central  Google Scholar 

Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA. 1986;256(24):3358–63.

Peter JG, Lehloenya R, Dlamini S, Risma K, White KD, Konvinse KC, et al. Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice. J Allergy Clin Immunol Pract. 2017;5(3):547–63.

Article  PubMed  PubMed Central  Google Scholar 

•• Copaescu A, Gibson A, Li Y, Trubiano JA, Phillips EJ. An updated review of the diagnostic methods in delayed drug hypersensitivity. Front Pharmacol. 2020;11:573573. Comprehensive recent review of in vivo and in vitro testing methods for delayed drug reactions.

Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071–80.

Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007;157(5):989–96.

Article  CAS  PubMed  Google Scholar 

•• de Groot AC. Patch testing in drug eruptions: practical aspects and literature review of eruptions and culprit drugs. Dermatitis. 2022;33(1):16–30. Review of patch testing in drug allergy with table of drug concentrations used in patch testing and tables of drugs known to have caused specific types of reactions that have shown positive patch testing results.

Barbaud A, Castagna J, Soria A. Skin tests in the work-up of cutaneous adverse drug reactions: A review and update. Contact Dermat. 2022;86(5):344–56.

Article  Google Scholar 

Barbaud A, Gonçalo M, Bruynzeel D, Bircher A, Dermatitis ESoC. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermat. 2001;45(6):321–8.

Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45–51.

CAS  PubMed  Google Scholar 

•• Woodruff CM, Botto N. The role of patch testing in evaluating delayed hypersensitivity reactions to medications. Clin Rev Allergy Immunol. 2022;62(3):548–61. Review providing guidance on patch testing technique.

Wolkenstein P, Chosidow O, Fléchet ML, Robbiola O, Paul M, Dumé L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermat. 1996;35(4):234–6.

Article  CAS  Google Scholar 

Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168(3):555–62.

Article  CAS  PubMed  Google Scholar 

Barbaud A. The use of skin testing in the investigation of toxidermia: from pathophysiology to the results of skin testing. Therapie. 2002;57(3):258–62.

CAS  PubMed  Google Scholar 

Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol. 2005;152(5):968–74.

Article  CAS  PubMed  Google Scholar 

Pinho A, Santiago L, Gonçalo M. Patch testing in the investigation of non-immediate cutaneous adverse drug reactions to metamizole. Contact Dermat. 2017;76(4):238–9.

Article  Google Scholar 

Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, Pouget-Jasson C, Amarger S, et al. A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol. 2010;20(4):461–4.

Article  PubMed  Google Scholar 

Andrade P, Brinca A, Gonçalo M. Patch testing in fixed drug eruptions–a 20-year review. Contact Dermat. 2011;65(4):195–201.

Article  Google Scholar 

Santiago F, Gonçalo M, Vieira R, Coelho S, Figueiredo A. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermat. 2010;62(1):47–53.

Article  CAS  Google Scholar 

• de Groot AC. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review. Contact Dermat. 2022;86(6):443–79. Review on the literature of systemic contact dermatitis including most common culprits, symptoms, and evaluation.

Pinho A, Coutinho I, Gameiro A, Gouveia M, Gonçalo M. Patch testing - a valuable tool for investigating non-immediate cutaneous adverse drug reactions to antibiotics. J Eur Acad Dermatol Venereol. 2017;31(2):280–7.

Article  CAS  PubMed  Google Scholar 

Phillips EJ, Sullivan JR, Knowles SR, Shear NH. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS. 2002;16(16):2223–5.

Article  PubMed  Google Scholar 

Rive CM, Bourke J, Phillips EJ. Testing for drug hypersensitivity syndromes. Clin Biochem Rev. 2013;34(1):15–38.

PubMed  PubMed Central  Google Scholar 

Novack DE, Braskett M, Worswick SD, Adler BL. Drug patch testing in Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review. Ann Allergy Asthma Immunol. 2023;130(5):628–36.

Article  CAS  PubMed  Google Scholar 

Lin YT, Chang YC, Hui RC, Yang CH, Ho HC, Hung SI, et al. A patch testing and cross-sensitivity study of carbamazepine-induced severe cutaneous adverse drug reactions. J Eur Acad Dermatol Venereol. 2013;27(3):356–64.

Article  CAS  PubMed  Google Scholar 

Hamanaka H, Mizutani H, Nouchi N, Shimizu Y, Shimizu M. Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol. Clin Exp Dermatol. 1998;23(1):32–4.

Article  CAS  PubMed  Google Scholar 

Emmerson BT, Hazelton RA, Frazer IH. Some adverse reactions to allopurinol may be mediated by lymphocyte reactivity to oxypurinol. Arthritis Rheum. 1988;31(3):436–40.

Article  CAS  PubMed  Google Scholar 

Schnyder B, Pichler WJ. Allergy to sulfonamides. J Allergy Clin Immunol. 2013;131(1):256–7.e1–5.

Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): A review and update. J Am Acad Dermatol. 2015;73(5):843–8.

Article  PubMed  Google Scholar 

Assier H, Valeyrie-Allanore L, Gener G, Verlinde Carvalh M, Chosidow O, Wolkenstein P. Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests. Contact Dermat. 2017;77(5):297–302.

Article  CAS  Google Scholar 

Katayama S, Ota M. Acute generalized exanthematous pustulosis due to a transdermal ketoprofen patch. Contact Dermat. 2022;86(5):425–7.

Article  CAS  Google Scholar 

Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JCL. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis. J Am Acad Dermatol. 2022;87(3):632–9.

Article  PubMed  Google Scholar 

Mashiah J, Brenner S. A systemic reaction to patch testing for the evaluation of acute generalized exanthematous pustulosis. Arch Dermatol. 2003;139(9):1181–3.

Article  PubMed  Google Scholar 

Sekhon S, Nedorost ST. Patch testing for adverse drug reactions. Cutis. 2017;99(1):49–54.

PubMed  Google Scholar 

• Barbaud A, Romano A. Skin testing approaches for immediate and delayed hypersensitivity reactions. Immunol Allergy Clin North Am. 2022;42(2):307–22. Review of testing in delayed drug reactions including skin prick, intradermal and patch testing.

Caballero ML, Quirce S. Delayed hypersensitivity reactions caused by drug excipients: a literature review. J Investig Allergol Clin Immunol. 2020;30(6):400–8.

Article  CAS  PubMed  Google Scholar 

Cham PM, Warshaw EM. Patch testing for evaluating drug reactions due to systemic antibiotics. Dermatitis. 2007;18(2):63–77.

Article  CAS  PubMed  Google Scholar 

Dilley M, Geng B. Immediate and delayed hypersensitivity reactions to antibiotics: aminoglycosides, clindamycin, linezolid, and metronidazole. Clin Rev Allergy Immunol. 2022;62(3):463–75.

Article  CAS  PubMed  Google Scholar 

Konvinse KC, Phillips EJ, White KD, Trubiano JA. Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Curr Opin Infect Dis. 2016;29(6):561–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doña I, Pérez-Sánchez N, Salas M, Barrionuevo E, Ruiz-San Francisco A, Hernández Fernández de Rojas D, et al. Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones. J Allergy Clin Immunol Pract. 2020;8(8):2707–14.e2.

Seitz CS, Bröcker EB, Trautmann A. Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy. 2009;39(11):1738–45.

Article  CAS  PubMed  Google Scholar 

Hausermann P, Scherer K, Weber M, Bircher AJ. Ciprofloxacin-induced acute generalized exanthematous pustulosis mimicking bullous drug eruption confirmed by a positive patch test. Dermatology. 2005;211(3):277–80.

Article  CAS  PubMed  Google Scholar 

Hoosen K, Mosam A, Dlova NC, Grayson W. An update on adverse cutaneous drug reactions in HIV/AIDS. Dermatopathology (Basel). 2019;6(2):111–25.

Article  PubMed  Google Scholar 

De Raeve L, Song M, Van Maldergem L. Adverse cutaneous drug reactions in AIDS. Br J Dermatol. 1988;119(4):521–3.

Article  PubMed  Google Scholar 

Jick H. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis. 1982;4(2):426–8.

Article  CAS  PubMed  Google Scholar 

van der Ven AJ, Koopmans PP, Vree TB, van der Meer JW. Adverse reactions to co-trimoxazole in HIV infection. Lancet. 1991;338(8764):431–3.

Article  PubMed  Google Scholar 

Bonfanti P, Pusterla L, Parazzini F, Libanore M, Cagni AE, Franzetti M, et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group. Biomed Pharmacother. 2000;54(1):45–9.

Krantz MS, Stone CA, Abreo A, Phillips EJ. Oral challenge with trimethoprim-sulfamethoxazole in patients with “sulfa” antibiotic allergy. J Allergy Clin Immunol Pract. 2020;8(2):757-60.e4.

Article  PubMed